Dražen Raucher

5.2k total citations · 1 hit paper
72 papers, 4.3k citations indexed

About

Dražen Raucher is a scholar working on Molecular Biology, Genetics and Biomaterials. According to data from OpenAlex, Dražen Raucher has authored 72 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 34 papers in Genetics and 18 papers in Biomaterials. Recurrent topics in Dražen Raucher's work include Connective tissue disorders research (34 papers), Cellular Mechanics and Interactions (16 papers) and Nanoparticle-Based Drug Delivery (13 papers). Dražen Raucher is often cited by papers focused on Connective tissue disorders research (34 papers), Cellular Mechanics and Interactions (16 papers) and Nanoparticle-Based Drug Delivery (13 papers). Dražen Raucher collaborates with scholars based in United States, Croatia and Germany. Dražen Raucher's co-authors include Michael P. Sheetz, Gene L. Bidwell, Jung Su Ryu, Ashutosh Chilkoti, Iqbal Massodi, Matthew R. Dreher, Dan E. Meyer, Kang Shen, Thomas P. Stauffer and Tobias Meyer and has published in prestigious journals such as Cell, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Dražen Raucher

71 papers receiving 4.2k citations

Hit Papers

Phosphatidylinositol 4,5-Bisphosphate Functions as a Seco... 2000 2026 2008 2017 2000 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dražen Raucher United States 32 2.1k 1.1k 1.1k 831 829 72 4.3k
Antonio Mario Tamburro Italy 36 1.5k 0.7× 369 0.3× 1.0k 1.0× 664 0.8× 1.8k 2.2× 130 4.0k
Cora‐Ann Schoenenberger Switzerland 31 1.9k 0.9× 1.5k 1.4× 308 0.3× 966 1.2× 356 0.4× 84 4.3k
Shun’ichi Kuroda Japan 42 3.7k 1.7× 659 0.6× 316 0.3× 744 0.9× 614 0.7× 196 5.8k
Toshinori Sato Japan 36 2.9k 1.4× 300 0.3× 603 0.6× 352 0.4× 424 0.5× 218 4.6k
Inge S. Zuhorn Netherlands 34 4.5k 2.1× 269 0.2× 1.7k 1.6× 1.6k 1.9× 850 1.0× 65 6.9k
Manorama Tewari United States 15 1.9k 0.9× 1.1k 1.0× 1.3k 1.3× 1.2k 1.5× 102 0.1× 17 4.3k
Ikuhiko Nakase Japan 43 6.3k 3.0× 328 0.3× 949 0.9× 576 0.7× 955 1.2× 121 7.5k
May C. Morris France 36 5.2k 2.5× 486 0.4× 536 0.5× 434 0.5× 936 1.1× 104 6.3k
Hongxia Zhao China 31 2.2k 1.0× 1.1k 1.0× 280 0.3× 465 0.6× 138 0.2× 66 3.8k
Jyoti K. Jaiswal United States 38 4.3k 2.0× 1.0k 1.0× 348 0.3× 1.1k 1.4× 182 0.2× 91 6.9k

Countries citing papers authored by Dražen Raucher

Since Specialization
Citations

This map shows the geographic impact of Dražen Raucher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dražen Raucher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dražen Raucher more than expected).

Fields of papers citing papers by Dražen Raucher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dražen Raucher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dražen Raucher. The network helps show where Dražen Raucher may publish in the future.

Co-authorship network of co-authors of Dražen Raucher

This figure shows the co-authorship network connecting the top 25 collaborators of Dražen Raucher. A scholar is included among the top collaborators of Dražen Raucher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dražen Raucher. Dražen Raucher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kopjar, Mirela, Dražen Raucher, Mary Ann Lila, & Josip Šimunović. (2024). Anti-Glioblastoma Potential and Phenolic Profile of Berry Juices. Processes. 12(2). 242–242. 4 indexed citations
3.
Raucher, Dražen, et al.. (2024). Bioactive Compounds, Antioxidant Activity, and Antiproliferative Potential on Glioblastoma Cells of Selected Stone Fruit Juices. Processes. 12(7). 1310–1310. 2 indexed citations
4.
Raucher, Dražen, et al.. (2023). Targeted c-Myc Inhibition and Systemic Temozolomide Therapy Extend Survival in Glioblastoma Xenografts. Bioengineering. 10(6). 718–718. 2 indexed citations
5.
Raucher, Dražen, et al.. (2022). In Vitro Comparison Between Ovine and Human Recombinant Hyaluronidase on Hyaluronic Acid Fillers. Facial Plastic Surgery & Aesthetic Medicine. 25(5). 391–395. 1 indexed citations
6.
Mitra, Dipanwita, et al.. (2020). Synthesis and biological evaluation of fluoro-substituted spiro-isoxazolines as potential anti-viral and anti-cancer agents. RSC Advances. 10(50). 30223–30237. 22 indexed citations
7.
Raucher, Dražen. (2019). Tumor targeting peptides: novel therapeutic strategies in glioblastoma. Current Opinion in Pharmacology. 47. 14–19. 72 indexed citations
8.
Raucher, Dražen, et al.. (2018). Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives. Frontiers in Oncology. 8. 624–624. 53 indexed citations
9.
Raucher, Dražen & Jung Su Ryu. (2015). Cell-penetrating peptides: strategies for anticancer treatment. Trends in Molecular Medicine. 21(9). 560–570. 190 indexed citations
10.
Shao, Qingmei, et al.. (2014). Focused Cerebellar Laser Light Induced Hyperthermia Improves Symptoms and Pathology of Polyglutamine Disease SCA1 in a Mouse Model. The Cerebellum. 13(5). 596–606. 2 indexed citations
11.
Ryu, Jung Su, et al.. (2014). Fusion of cell-penetrating peptides to thermally responsive biopolymer improves tumor accumulation of p21 peptide in a mouse model of pancreatic cancer. Drug Design Development and Therapy. 8. 1649–1649. 18 indexed citations
12.
Ryu, Jung Su & Dražen Raucher. (2014). Elastin-like polypeptide for improved drug delivery for anticancer therapy: preclinical studies and future applications. Expert Opinion on Drug Delivery. 12(4). 653–667. 29 indexed citations
13.
Lyons, Daniel F., Vu Le, Gene L. Bidwell, et al.. (2013). Structural and Hydrodynamic Analysis of a Novel Drug Delivery Vector: ELP[V5G3A2-150]. Biophysical Journal. 104(9). 2009–2021. 22 indexed citations
14.
Bidwell, Gene L., Eddie Perkins, Joshua Hughes, et al.. (2013). Thermally Targeted Delivery of a c-Myc Inhibitory Polypeptide Inhibits Tumor Progression and Extends Survival in a Rat Glioma Model. PLoS ONE. 8(1). e55104–e55104. 96 indexed citations
15.
16.
Perkins, Eddie, et al.. (2012). Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative. International Journal of Pharmaceutics. 436(1-2). 825–832. 59 indexed citations
17.
Lyons, Daniel F., Gene L. Bidwell, Wolfgang Krämer, Dražen Raucher, & John J. Correia. (2011). Biophysical Characterization of an Elastin-Like-Polypeptide. Biophysical Journal. 100(3). 540a–540a. 1 indexed citations
18.
Bidwell, Gene L., et al.. (2010). A thermally targeted peptide inhibitor of symmetrical dimethylation inhibits cancer-cell proliferation. Peptides. 31(5). 834–841. 33 indexed citations
19.
Raucher, Dražen, et al.. (2009). Therapeutic peptides for cancer therapy. Part II – cell cycle inhibitory peptides and apoptosis-inducing peptides. Expert Opinion on Drug Delivery. 6(10). 1049–1064. 42 indexed citations
20.
Bidwell, Gene L. & Dražen Raucher. (2005). Enhancing the antiproliferative effect of topoisomerase II inhibitors using a polypeptide inhibitor of c-Myc. Biochemical Pharmacology. 71(3). 248–256. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026